Markets:

Overview

News

Currencies

International

Treasuries

Revelation Biosciences, Inc. - Common Stock (NQ:REVB)

1.920 -0.110 (-5.42%)

Streaming Delayed Price Updated: 12:12 PM EST, Feb 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Revelation Biosciences, Inc. - Common Stock

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Why Revelation Biosciences Is Trading 40% Lower Thursday ↗

February 09, 2023

Revelation Biosciences Inc (NASDAQ: REVB) shares are trading lower by 41.98% Thursday afternoon. The company priced a 3.225 million share offering for gross proceeds of $15.6 million. What Else?

Via Benzinga

Why Tivic Health Systems Are Trading Lower By 55%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

February 09, 2023

Gainers Hempacco Co., Inc. (NASDAQ: HPCO) rose 296% to $2.99 after declining 6% on Wednesday.

Via Benzinga

US Stocks Turn Lower; Dow Drops 50 Points ↗

February 09, 2023

U.S. stocks turned lower midway through trading, with the Dow Jones dropping around 50 points on Thursday. The Dow traded down 0.15% to 33,897.48 while the NASDAQ fell 0.12% to 11,896.28. The S&P 500...

Via Benzinga

Revelation Biosciences Outlines Plans Human Trial For Lead Fibrosis Candidate ↗

November 18, 2022

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

February 09, 2023

Via Benzinga

Wall Street Cautiously Optimistic At Midday ↗

February 09, 2023

The Dow Jones Industrial Average is up 108 points midday. The S&P 500 and Nasdaq Composite are both higher as well.

Via Talk Markets

Dow Jumps 250 Points; US Jobless Claims Increase Last Week ↗

February 09, 2023

U.S. stocks traded higher this morning, with the Dow Jones jumping around 250 points on Thursday. The Dow traded up 0.75% to 34,204.99 while the NASDAQ rose 1.15% to 12,047.28. The S&P 500 also rose,...

Via Benzinga

Revelation Biosciences Inc. Announces Pricing of $15.6 Million Public Offering

February 09, 2023

From Revelation Biosciences Inc.

Via Business Wire

Why Cardiovascular Systems Shares Are Trading Higher By 48%; Here Are 20 Stocks Moving Premarket ↗

February 09, 2023

Gainers

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

February 09, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

February 09, 2023

We're starting off another day of trading with a look at the biggest pre-market stock movers investors need to watch for Wednesday!

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

February 08, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

February 08, 2023

On Wednesday, 20 companies achieved new lows for the year.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

February 07, 2023

Via Benzinga

Revelation Biosciences Reveals Encouraging Preclinical Data From Its Lead Fibrosis Candidate ↗

February 07, 2023

Via Benzinga

Revelation Biosciences Inc. Announces Preclinical Biomarker Data Supporting Activity of REVTx-300

February 07, 2023

From Revelation Biosciences Inc.

Via Business Wire

Revelation Biosciences Inc. Announces 1-for-35 Reverse Stock Split effective February 1, 2023 and Results of Special Meeting of Stockholders

January 31, 2023

From Revelation Biosciences Inc.

Via Business Wire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

January 24, 2023

Via Benzinga

Why LogicMark Shares Are Trading Lower By Around 25%; Here Are 20 Stocks Moving Premarket ↗

January 24, 2023

Gainers Axcella Health Inc. (NASDAQ: AXLA) rose 71.7% to $0.7450 in pre-market trading after the company reported regulatory path to registration of AXA1125 for long COVID-19 fatigue.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

January 17, 2023

Via Benzinga

Revelation Biosciences Inc. Announces Mandatory Unit Separation to Occur on January 13, 2023

January 10, 2023

From Revelation Biosciences Inc.

Via Business Wire

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

January 10, 2023

We're starting off the day with an overview of the biggest pre-market stock movers traders need to know about for Tuesday!

Via InvestorPlace

12 Health Care Stocks Moving In Friday's After-Market Session ↗

January 06, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

December 13, 2022

We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about for Tuesday morning!

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

December 02, 2022

We're starting off the day with an overview of the biggest pre-market stock movers traders need to know about for Friday morning!

Via InvestorPlace

Earnings Scheduled For November 21, 2022 ↗

November 21, 2022

Companies Reporting Before The Bell • Zepp Health (NYSE:ZEPP) is expected to report quarterly earnings at $0.54 per share on revenue of $186.58 million.

Via Benzinga

Revelation Biosciences Inc. Announces Future Clinical Development Plans Based on Recent Biomarker Analysis and Significant Reduction in New Collagen Deposition (Fibrosis) in Preclinical Model

November 18, 2022

From Revelation Biosciences Inc.

Via Business Wire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

November 15, 2022

Via Benzinga

Revelation Biosciences Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2022 and Recent Corporate Progress

November 10, 2022

From Revelation Biosciences Inc.

Via Business Wire

Stocks That Hit 52-Week Lows On Thursday ↗

November 10, 2022

During Thursday's session, 97 companies made new 52-week lows.

Via Benzinga

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.